Coltuximab ravtansine
- Generic Name
- Coltuximab ravtansine
- Drug Type
- Biotech
- CAS Number
- 1269764-99-9
- Unique Ingredient Identifier
- MRS84YT9L2
Overview
Coltuximab ravtansine (SAR3419) targets CD19 and is being investigated for the treatment of acute lymphoblastic leukemia (ALL).
Background
Coltuximab ravtansine (SAR3419) targets CD19 and is being investigated for the treatment of acute lymphoblastic leukemia (ALL).
Indication
Investigated for use/treatment in lymphoma (non-hodgkin's).
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath